Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
İ̇stanbul
-
Istanbul, İ̇stanbul, Turkey, 34000
- Pinar Yalcin Bahat
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- covid -19 positive and negative pregnant women
- have no psychiatric illness
- not using antidepressants or antipsychotic drugs
Exclusion Criteria:
- women with psychiatric illness
- using antidepressants or antipsychotic drugs
- not pregnant
- adolescent pregnancy
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
covid -19 positive pregnant women
Maternal attachment, Edinburgh depression scoring, and postpartum anxiety scale are evaluated in 250 covid-positive pregnant women in the 3rd month after birth.
|
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.
|
|
covid -19 negative pregnant women
Maternal attachment, Edinburgh depression scoring, and postpartum anxiety scale are evaluated in 250 covid-negative pregnant women in the 3rd month after birth.
|
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal attachment in SARS- cov2 positive and negative pregnant women
Time Frame: 3 months
|
Maternal attachment scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth.
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.
High scores from the scale indicate high maternal attachment.
|
3 months
|
|
Edinburgh depression scores in in SARS- cov2 positive and negative pregnant women
Time Frame: 3 months
|
Edinburgh depression scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth.
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.
All questions are scored between 0 and 3 and the highest possible score on the scale is 30.
and shows advanced depression.
|
3 months
|
|
Postpartum anxiety scale scores in in SARS- cov2 positive and negative pregnant women
Time Frame: 3 months
|
Postpartum anxiety scale scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth.
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.
It can be said that the postpartum anxiety levels of those who score 73 and below on the scale are low, those who score between 74 and 100 are medium, and those who score 101 and above are high.
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Mood Disorders
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Depression
- Depressive Disorder
- COVID-19
- Anxiety Disorders
Other Study ID Numbers
Other Study ID Numbers
- maternalattachmentcovid
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.